This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients (IFaB)

This study has been withdrawn prior to enrollment.
(Recruitment problems)
Sponsor:
Information provided by (Responsible Party):
Holger Cramer, Universität Duisburg-Essen
ClinicalTrials.gov Identifier:
NCT01686737
First received: September 12, 2012
Last updated: February 4, 2013
Last verified: February 2013
  Purpose

Breast cancer is the most frequent cancer in women and is associated with profound restrictions of health-related quality of life and psychosocial health. More than three-quarters of women with breast cancer suffer from fatigue during cancer treatment. While exercise interventions can improve fatigue in breast cancer patients, many patients request complementary treatment approaches. Therefore, this study investigates the effects of yoga in women with breast cancer compared to aerobic exercise and usual care.

It is hypothesized that yoga is more effective than usual care and equally effective as aerobic exercise.


Condition Intervention
Breast Neoplasms Fatigue Behavioral: Iyengar Yoga Behavioral: Walking

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer Patients

Resource links provided by NLM:


Further study details as provided by Holger Cramer, Universität Duisburg-Essen:

Primary Outcome Measures:
  • Fatigue [ Time Frame: Week 12 ]
    Multidimensional Fatigue Inventory


Secondary Outcome Measures:
  • Fatigue [ Time Frame: Week 36 ]
    Multidimensional Fatigue Inventory

  • Health-related quality of life [ Time Frame: Week 12, week 36 ]
    Functional Assessment of Cancer Therapy - Breast

  • Depression and anxiety [ Time Frame: Week 12, week 36 ]
    Hospital Anxiety and Depression Scale

  • Sleep quality [ Time Frame: Week 12, week 36 ]
    Pittsburgh Sleep Quality Index

  • Perceived Stress [ Time Frame: Week 12, week 36 ]
    • Perceived Stress Scale
    • Impact of Event Scale

  • Salivary Cortisol [ Time Frame: Week 12, week 36 ]
    Cortisol awakening response

  • Safety [ Time Frame: Week 0-36 ]
    Adverse events


Enrollment: 0
Study Start Date: November 2012
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Yoga

Iyengar Yoga

  • 12 weeks of Iyengar yoga
  • 2 weekly sessions of 60 minutes
Behavioral: Iyengar Yoga
  • 12 weeks of Iyengar yoga
  • 2 weekly sessions of 60 minutes
Active Comparator: Aerobic exercise

Walking

  • 12 weeks of walking
  • 2 weekly sessions of 60 minutes
Behavioral: Walking
  • 12 weeks of walking
  • 2 weekly sessions of 60 minutes
No Intervention: Usual Care

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • non-metastatic invasive breast cancer
  • currently receiving adjuvant chemotherapy
  • moderate to severe chemotherapy-induced fatigue
  • physical and cognitive capacity to participate in yoga or walking

Exclusion Criteria:

  • diagnosed and pharmacologically treated psychiatric disorder except depressive adaptation disorder as a reaction to cancer diagnosis
  • ECOG status > 1
  • prior malignancy with a disease-free survival < 10 years except curatively treated basalioma of the skin and carcinoma in situ of the cervix
  • prior ductal carcinoma in situ (DCIS) ot the breast
  • pregnancy or breastfeeding
  • regular practice of yoga or walking during the past 12 months
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01686737

Locations
Germany
Klinik für Senologie / Brustzentrum, Kliniken Essen-Mitte
Essen, Germany, 45136
Brustzentrum Köln-Hohenlind, St. Elisabeth-Krankenhaus Köln-Hohenlind
Köln, Germany, 50935
Sponsors and Collaborators
Universität Duisburg-Essen
Investigators
Principal Investigator: Holger Cramer, PhD University of Duisburg-Essen, Chair of Complementary and Integrative Medicine
Study Director: Gustav J. Dobos, MD University of Duisburg-Essen, Chair of Complementary and Integrative Medicine
  More Information

Responsible Party: Holger Cramer, Postdoctoral fellow, Universität Duisburg-Essen
ClinicalTrials.gov Identifier: NCT01686737     History of Changes
Other Study ID Numbers: 2012210
Study First Received: September 12, 2012
Last Updated: February 4, 2013

Additional relevant MeSH terms:
Fatigue
Breast Neoplasms
Signs and Symptoms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on June 21, 2017